reviewFrontiers in ImmunologyJul 10, 2020GOLD OA

Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies

Zhejiang Chinese Medical University

PubMed
Indexed incrossrefdoajpubmed

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) is the pathogen that causes coronavirus disease 2019 (COVID-19). As of 25 May 2020, the outbreak of COVID-19 has caused 347,192 deaths around the world. The current evidence showed that severely ill patients tend to have a high concentration of pro-inflammatory cytokines, such as interleukin (IL)-6, compared to those who are moderately ill. The high level of cytokines also indicates a poor prognosis in COVID-19. Besides, excessive infiltration of pro-inflammatory cells, mainly involving macrophages and T-helper 17 cells, has been found in lung tissues of patients with COVID-19 by postmortem examination. Recently, increasing studies indicate that the…

Citation impact

1,143
total citations
FWCI
24.76
Percentile
100%
References
136
Citations per year

Authors

6

Topics & keywords

Keywords
  • Cytokine storm
  • Cytokine
  • Medicine
  • Tocilizumab
  • Cytokine release syndrome
  • Immunology
  • Coronavirus
  • Outbreak
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding